Literature DB >> 24762400

Adherence barriers to chronic dialysis in the United States.

Kevin E Chan1, Ravi I Thadhani2, Franklin W Maddux3.   

Abstract

Hemodialysis patients often do not attend their scheduled treatment session. We investigated factors associated with missed appointments and whether such nonadherence poses significant harm to patients and increases overall health care utilization in an observational analysis of 44 million hemodialysis treatments for 182,536 patients with ESRD in the United States. We assessed the risk of hospitalization, emergency room visit, or intensive-coronary care unit (ICU-CCU) admission in the 2 days after a missed treatment relative to the risk for patients who received hemodialysis. Over the 5-year study period, the average missed treatment rate was 7.1 days per patient-year. In covariate adjusted logistic regression, the risk of hospitalization (odds ratio [OR], 3.98; 95% confidence interval [95% CI], 3.93 to 4.04), emergency room visit (OR, 2.00; 95% CI, 1.87 to 2.14), or ICU-CCU admission (OR, 3.89; 95% CI, 3.81 to 3.96) increased significantly after a missed treatment. Overall, 0.9 missed treatment days per year associated with suboptimal transportation to dialysis, inclement weather, holidays, psychiatric illness, pain, and gastrointestinal upset. These barriers also associated with excess hospitalization (5.6 more events per patient-year), emergency room visits (1.1 more visits), and ICU-CCU admissions (0.8 more admissions). In conclusion, poor adherence to hemodialysis treatments may be a substantial roadblock to achieving better patient outcomes. Addressing systemic and patient barriers that impede access to hemodialysis care may decrease missed appointments and reduce patient morbidity.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Year:  2014        PMID: 24762400      PMCID: PMC4214530          DOI: 10.1681/ASN.2013111160

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  14 in total

1.  In-center hemodialysis attendance: patient perceptions of risks, barriers, and recommendations.

Authors:  Kara B Chenitz; Michael Fernando; Judy A Shea
Journal:  Hemodial Int       Date:  2014-01-22       Impact factor: 1.812

2.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

3.  Longitudinal data analysis for generalized linear models under participant-driven informative follow-up: an application in maternal health epidemiology.

Authors:  Petra Bůzková; Elizabeth R Brown; Grace C John-Stewart
Journal:  Am J Epidemiol       Date:  2009-12-09       Impact factor: 4.897

4.  Depression: a common but underrecognized condition associated with end-stage renal disease.

Authors:  Pei-Li Wang; Suzanne G Watnick
Journal:  Semin Dial       Date:  2004 May-Jun       Impact factor: 3.455

5.  Patient dialysis knowledge is associated with permanent arteriovenous access use in chronic hemodialysis.

Authors:  Kerri L Cavanaugh; Rebecca L Wingard; Raymond M Hakim; Tom A Elasy; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 8.237

6.  Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

Authors:  Rajiv Saran; Jennifer L Bragg-Gresham; Hugh C Rayner; David A Goodkin; Marcia L Keen; Paul C Van Dijk; Kiyoshi Kurokawa; Luis Piera; Akira Saito; Shunichi Fukuhara; Eric W Young; Philip J Held; Friedrich K Port
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

7.  Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.

Authors:  J S Weissman; C Gatsonis; A M Epstein
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

8.  Access barriers to health care for Latino children.

Authors:  G Flores; M Abreu; M A Olivar; B Kastner
Journal:  Arch Pediatr Adolesc Med       Date:  1998-11

9.  Noncompliance in hemodialysis: predictors and survival analysis.

Authors:  J E Leggat; S M Orzol; T E Hulbert-Shearon; T A Golper; C A Jones; P J Held; F K Port
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

10.  The prevalence and treatment of depression among patients starting dialysis.

Authors:  Suzanne Watnick; Paul Kirwin; Rex Mahnensmith; John Concato
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  30 in total

1.  Patient knowledge and adherence to maintenance hemodialysis: an International comparison study.

Authors:  Kana N Miyata; Jenny I Shen; Yasuhide Nishio; Manabu Haneda; Kobena A Dadzie; Nijal R Sheth; Renjiro Kuriyama; Chika Matsuzawa; Ken Tachibana; Nikolas B Harbord; James F Winchester
Journal:  Clin Exp Nephrol       Date:  2017-11-28       Impact factor: 2.801

2.  Association of Emergency-Only vs Standard Hemodialysis With Mortality and Health Care Use Among Undocumented Immigrants With End-stage Renal Disease.

Authors:  Lilia Cervantes; Delphine Tuot; Rajeev Raghavan; Stuart Linas; Jeff Zoucha; Lena Sweeney; Chandan Vangala; Madelyne Hull; Mario Camacho; Angela Keniston; Charles E McCulloch; Vanessa Grubbs; Jessica Kendrick; Neil R Powe
Journal:  JAMA Intern Med       Date:  2018-02-01       Impact factor: 21.873

3.  Depressive affect and hospitalization risk in incident hemodialysis patients.

Authors:  Eduardo Lacson; Lisa Bruce; Nien-Chen Li; Ann Mooney; Franklin W Maddux
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 8.237

4.  Psychiatric Illness and Mortality in Hospitalized ESKD Dialysis Patients.

Authors:  Paul L Kimmel; Chyng-Wen Fwu; Kevin C Abbott; Marva M Moxey-Mims; Susan Mendley; Jenna M Norton; Paul W Eggers
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-22       Impact factor: 8.237

5.  Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.

Authors:  N Massamba; A Dirani; J Knoeri; B Pasquier; A Ingram; G Soubrane
Journal:  Eye (Lond)       Date:  2015-07-24       Impact factor: 3.775

Review 6.  Applying A Biopsychosocial Framework to Achieve Durable Behavior Change in Kidney Disease.

Authors:  Devika Nair; Daniel Cukor; Warren D Taylor; Kerri L Cavanaugh
Journal:  Semin Nephrol       Date:  2021-11       Impact factor: 5.299

7.  Combined effects of air pollution and extreme heat events among ESKD patients within the Northeastern United States.

Authors:  Richard V Remigio; Hao He; Jochen G Raimann; Peter Kotanko; Frank W Maddux; Amy Rebecca Sapkota; Xin-Zhong Liang; Robin Puett; Xin He; Amir Sapkota
Journal:  Sci Total Environ       Date:  2021-12-16       Impact factor: 7.963

8.  Association of the Comprehensive ESRD Care Model with Treatment Adherence.

Authors:  Richard A Hirth; Tammie Nahra; Jonathan H Segal; Joseph Gunden; Grecia Marrufo; Brighita Negrusa; Gregory Boyer; Amy Jiao; Kathryn Sleeman; Claudia Dahlerus; Jennifer Wiens; Darin Ullman; Kelsey Bacon; Daniel Strubler; Rebecca Braun; Ariana Ackerman; Yi Li
Journal:  Kidney360       Date:  2021-12-21

9.  Renal Failure Patients in Disasters.

Authors:  Kenneth D Lempert; Jeffrey B Kopp
Journal:  Disaster Med Public Health Prep       Date:  2019-05-06       Impact factor: 1.385

10.  Geographic disparities in mortality among the end stage renal disease patients: an analysis of the United States Renal Data System, 2007-08.

Authors:  Fozia Ajmal; Kevin J Bennett; Janice C Probst
Journal:  J Nephrol       Date:  2016-06-16       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.